Skip to main content
. Author manuscript; available in PMC: 2010 Jun 1.
Published in final edited form as: Acta Neuropathol. 2009 Apr 28;117(6):613–634. doi: 10.1007/s00401-009-0538-8

Figure 11.

Figure 11

Graphic depiction of differential characteristics of the subjects classified by the proposed unified Lewy body staging system. For all graphs, the 0 stage data is from the normal control group. a) Incidental Lewy body disease (ILBD) subjects classified by Unified Lewy body stage. b) Parkinson’s disease (PD) subjects classified by Unified Lewy body stage. c) Dementia with Lewy bodies (DLB) subjects classified by Unified Lewy body stage. e) Unified Lewy body stage by striatal TH concentration. Subjects with ADLB were excluded from the analysis. Error bars show standard error of the mean. The means of the stages differed significantly (p < 0.001). f) Unified Lewy body stage by substantia nigra pigmented neuron loss score. All subjects with Lewy body pathology were included. Error bars indicate standard deviation. The means of the stages differed significantly (p < 0.001).